DAFALGAN Dolo cpr 500 mg 16 pce
7680475040027
CH-47504
N02BE01
01.01.1.
1 / 3
google
Details
- Product number
- 4750401
- CPT
- -
- Packaging group
- 16
- Unit
- Tablette(n)
- Composition
- paracetamolum 500 mg, hypromellosum, povidonum, carmellosum natricum conexum corresp. natrium ca. 1 mg, cellulosum microcristallinum, glyceroli dibehenas, magnesii stearas pro compresso.
Articles (1)
Dafalgan DOLO, Tabletten
Tabletten
16
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 47504
- Drug name
- Dafalgan DOLO, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 03/12/1986
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN Dolo cpr 500 mg 16 pce
- Description (DE)
- DAFALGAN Dolo Tabl 500 mg 16 Stk
- Market launch
- 03/12/1986
- Narcotic (BTM)
- No